Rivoceranib mesylateProduct ingredient for Rivoceranib

Show full entry for Rivoceranib
Name
Rivoceranib mesylate
Drug Entry
Rivoceranib

Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).

See full entry for Rivoceranib
Accession Number
DBSALT003305
Structure
Synonyms
Apatinib mesylate
External IDs
YN-968D1 / YN968D1
UNII
TK02X14ASJ
CAS Number
1218779-75-9
Not Available
Predicted Properties
Not Available